Haemonetics Corporation (United States) is listed on the Nasdaq and has a market capitalization of $5.62 billion, with shareholders equity totaling $898.50 million.
The company employs approximately 3.009 people and operates in the Other sector, within the Other industry.
Over the past 12 months, Haemonetics Corporation reported $1.38 billion in revenue, generating net income of $103.91 million.
Key financial metrics include a P/E ratio of 54.13, a price-to-book (P/B) ratio of 6.26, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker HAE.